To analyze trends within the mesenchymal stem cell (MSC) industry, it is valuable to consider grant rate data. Previously, the U.S. federal government operated an online tool called CRISP (“Computer Retrieval of Information on Scientific Projects”). It was a searchable database of federally funded biomedical research projects conducted at universities, hospitals, and other U.S. research institutions. The database allowed users to search the CRISP interface for grants funding for specific types of scientific research, using text-based search terms.
However, that has since been replaced by RePORTer (Research Portfolio Online Reporting Tools)1, a more powerful database and search tool supported by the U.S. Department of Health and Human Services. RePORTer allows users to search a comprehensive repository of National Institutes of Health (NIH) funded research projects resulting from NIH funding.
Furthermore, it allows users to search for a term within the Title, Project Terms, or Project Abstract, of all grants contained within the database. In the year-by-year analysis below, the following set of search terms pertaining to mesenchymal stem cells was used: “mesenchymal stem cell” OR “mesenchymal stem cells” OR “mesenchymal stromal cell” OR “mesenchymal stromal cells”.
Because RePORTer searches are not case-sensitive, there is no difference between a search for “mesenchymal stem cell” and “Mesenchymal Stem Cell.” Therefore, all of the above searches are lower case. Most important for this analysis are the results that contain the above search terms within the Title of the grant only, because this means the grant is specific to MSC research.
Results for those search terms within the Title, Project Terms, and Project Abstract, are not shown below, because these results may be for reference or comparison purposes, and not directly indicative of the study of MSCs within the context of the grant.
2015 Fiscal Year Grants Awarded by the NIH to Support MSC Research Projects
The table below contains a complete list of grants with the identified search terms appearing within the Title of the grant during the 2015 Fiscal Year (RePORTer database).
Leading Principal Investigators Receiving Grants to Support MSC Research Projects (All-Time Analysis)
It is also interesting to consider the principal investigators who are most successful at acquiring MSC grant funding, receiving substantial support from the NIH over time. In this all-time analysis (no date restrictions), there are three researchers who have received funding for nine MSC projects so far and another researcher who has received funding for eight MSC projects.
These four individuals (highlighted in the table below) represent the investigators who are most effective at acquiring NIH-support for their MSC research projects.
TABLE: Leading Principal Investigators Receiving Grant Funding for MSC Research (Sorted by # of Funded Projects)
Source: Report.nih.gov,. ‘NIH Research Portfolio Online Reporting Tools (Report)’. 2015. Web. 30 Sept. 2015.
BioInformant is the first and only market research firm to specialize exclusively in the stem cell industry. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, and Becton Dickinson, BioInformant is your global leader in stem cell industry data.
To learn more, view the global strategic report “Mesenchymal Stem Cells – Advances & Applications.”